Inhibition of hepatic and intestinal CYP3A4 by mibefradil measured by the erythromycin breath test (EBT) and oral midazolam pharmacokinetics (PK)
VERONESE, M, GILLEN, L, DORVAL, E, HAUCK, W, WALDMAN, S, GREENBERG, HVolume:
65
Language:
english
Pages:
1
Journal:
Clinical Pharmacology & Therapeutics
DOI:
10.1016/s0009-9236(99)80058-7
Date:
February, 1999
File:
PDF, 117 KB
english, 1999